Ozempic for addiction:
How an elite rehab center is using GLP-1s to ‘obliterate’ all kinds of cravings

This in-depth piece by Stat News highlights Caron's leadership of Dr. Steven Klein, Dr. Mo Sarhan, and Dr. Adam Scioli, and offers an honest look at the potential, complexity, and early clinical success of this emerging treatment modality. It also speaks to the heart of Caron's mission—meeting patients where they are with compassionate, evidence-informed care.

Read the Stat News article here: Ozempic for addiction: How an elite rehab center is using GLP-1s to ‘obliterate’ all kinds of cravings